Vectors Research Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Vectors Research Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17	Closed	-$2K	–	256
2022 Q2	$2K	Hold	17	–	–	﹤0.01%	464
2022 Q1	$3K	Hold	17	–	–	﹤0.01%	424
2021 Q4	$3K	Hold	17	–	–	﹤0.01%	541
2021 Q3	$3K	Buy	+17	New	+$2.9K	﹤0.01%	442

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Vectors Research Management's FBT Position: Q3 2022 in Review

Vectors Research Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 17 shares — an estimated $2K sold.

Vectors Research Management first reported a position in FBT in Q3 2021 and held it in 4 quarters. The position peaked at $3K in Q1 2022. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

Vectors Research Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 17 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $2K.
Vectors Research Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2021 and held it in 4 quarters.
Vectors Research Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3K in Q1 2022.
218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.